Chen et al. [19] demonstrated that BRACs treatment promoted a reduction in JNK mRNA levels; however, in the study conducted by Layosa et al. (2021) [26], ACN promoted the upregulation of JNK and p38, which culminated in the activation of apoptosis and reduced migration of tumor cells. Here, MAPK8 is linked to neoplasm.